Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Builders Firstsource buy BiotechBee

Start price
€138.35
03.09.23 / 70%
Target price
€200.00
30.11.25
Performance (%)
-5.49%
End price
€130.75
02.12.23
Summary
This prediction ended on 02.12.23 with a price of €130.75. With a performance of -5.49%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m
Builders Firstsource -16.832% -16.832%
iShares Core DAX® 2.749% 4.620%
iShares Nasdaq 100 0.470% -0.331%
iShares Nikkei 225® -2.930% -5.556%
iShares S&P 500 0.679% 0.631%

According to BiotechBee what are the pros and cons of Builders Firstsource for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Builders Firstsource diskutieren
Prediction Buy
Perf. (%) -5.49%
Target price 200.000
Change
Ends at 30.11.25

Buy mit Kursziel 200,0

In the thread Trading Builders Firstsource
Prediction Buy
Perf. (%) -5.49%
Target price 200.000
Change
Ends at 30.11.25

Buy beendet